Paratek Pharmaceuticals Inc
Paratek Pharmaceuticals Inc
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Omadacycline for Treatment Refractory Mycoplasma Genitalium Urethritis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, urethral disorder, urethritis, urinary system disorder | Not yet recruiting | Phase 2 | 2026-10-02 | NCT07853742 | |
| Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps | Chronic Rhinosinusitis Without Nasal Polyps | Recruiting | Phase 3 | 2026-09-18 | NCT06850805 | |
| Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection | Bone Infection; Bone and Joint Infection; Joint Infection | Active, not recruiting | Phase 2 | 2026-01-14 | NCT05753215 |